Illinois 104th General Assembly Status: Introduced 8 D cosponsors

SB3801      — PRESCRIPTION LABELING

Last action — Rule 3-9(a) / Re-referred to Assignments

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the Senate. Introduced February 06, 2026. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Not enough signal yet

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Amends the Medical Practice Act of 1987. In provisions concerning legend drugs, provides that, at the request of a person dispensing a drug or medicine, the label affixed to a box, bottle, vessel, or package containing mifepristone, misoprostol, or any generic alternative may include the name of the dispensing health care practice instead of the name of the person dispensing the drug or medicine. Amends the Pharmacy Practice Act. In provisions concerning the label of a drug, medicine, or poison that is lawfully sold or dispensed, provides that, at a prescriber's request, the label affixed to a box, bottle, vessel, or package containing mifepristone, misoprostol, or any generic alternative may include the name of the prescribing health care practice instead of the name of the prescriber.

Bill Text

We don't have the full text on file for this bill yet.

Read SB3801 on the official Illinois source →

Action History

  1. Rule 3-9(a) / Re-referred to Assignments

  2. Added as Co-Sponsor Sen. Graciela Guzmán

  3. Rule 2-10 Committee Deadline Established As April 24, 2026

  4. Added as Co-Sponsor Sen. Emil Jones, III

  5. Postponed - Executive

  6. Added as Co-Sponsor Sen. Mattie Hunter

  7. Rule 2-10 Committee Deadline Established As March 27, 2026

  8. Postponed - Executive

  9. Added as Co-Sponsor Sen. Adriane L. Johnson

  10. Added as Co-Sponsor Sen. Mark L. Walker

  11. Added as Co-Sponsor Sen. Suzy Glowiak Hilton

  12. Assigned to Executive

  13. Added as Co-Sponsor Sen. Rachel Ventura

  14. Referred to Assignments

  15. First Reading

  16. Filed with Secretary by Sen. Celina Villanueva

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 7 co-sponsors · 175 not signed on

Sponsors (1)

Co-sponsors (7)

Not signed on (175)

175 members have not signed on to this bill.

Show all 175 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB3801      do?
Amends the Medical Practice Act of 1987. In provisions concerning legend drugs, provides that, at the request of a person dispensing a drug or medicine, the label affixed to a box, bottle, vessel, or package containing mifepristone, misoprostol, or any generic alternative may include the name of the dispensing health care practice instead of the name of the person dispensing the drug or medicine. Amends the Pharmacy Practice Act. In provisions concerning the label of a drug, medicine, or poison that is lawfully sold or dispensed, provides that, at a prescriber's request, the label affixed to a box, bottle, vessel, or package containing mifepristone, misoprostol, or any generic alternative may include the name of the prescribing health care practice instead of the name of the prescriber.
Who sponsors SB3801     ?
SB3801      is sponsored by Celina Villanueva (Democrat), Rachel Ventura (Democrat), Suzy Glowiak Hilton (Democrat), Mark L. Walker (Democrat), Adriane L. Johnson (Democrat), Mattie Hunter (Democrat), Emil Jones, III (Democrat), and Graciela Guzmán (Democrat).
What is the current status of SB3801     ?
This bill has been introduced in the Senate. Introduced February 06, 2026. It must pass committee before a floor vote.
Where can I track SB3801     ?
Track SB3801      free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB3801     

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB3801     

Last checked for changes about 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →